SCHEMBL5274279

SCHEMBL5274279

CCCN(CCOc1ccccc1C(=O)O)c1nc2ccccc2o1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.49
PPARA Q07869 16/20 0.49
PPARD Q03181 11/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272201 0.95 PPARA (0.51) PPARGPPARAPPARD
SCHEMBL5277585 0.94 PPARA (0.52) PPARGPPARAPPARD
SCHEMBL5579706 0.94 PPARA (0.52) PPARGPPARAPPARD
SCHEMBL5271988 0.92 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL5276379 0.92 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL5579724 0.91 PPARA (0.52) PPARGPPARAPPARD
SCHEMBL5274267 0.89 PPARA (0.58) PPARGPPARAPPARD
SCHEMBL5276156 0.89 PPARG (0.58) PPARGPPARAPPARD
SCHEMBL5273658 0.89 PPARA (0.58) PPARGPPARAPPARD
SCHEMBL14366174 0.88 PPARA (0.58) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
US-7301033-B2 PPAR-activating compound KOWA CO., LTD. (JP) 2007-11-27 US disclosed
EP-1857447-A1 PPAR-ACTIVATING COMPOUND Kowa Company, Ltd. (JP) 2007-11-21 EP disclosed
US-20060167058-A1 PPAR-activating compound KOWA CO., LTD. (JP) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167058-A1 PPAR-activating compound PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.